The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma.
AlphaFold, meet AlphaMissense: Google DeepMind’s AI successor predicts how 71M mutations cause disease
Google DeepMind has developed an AI system that predicts the chances that tens of millions of genetic variants will cause disease. Called AlphaMissense, the technology